These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2858016

  • 1. Ifosfamide/mesa and encephalopathy.
    Cantwell BM, Harris AL.
    Lancet; 1985 Mar 30; 1(8431):752. PubMed ID: 2858016
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
    Hilgard P, Burkert H.
    Eur J Cancer Clin Oncol; 1984 Nov 30; 20(11):1451-2. PubMed ID: 6437825
    [No Abstract] [Full Text] [Related]

  • 16. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ, Watkin SW.
    Lancet; 1988 May 14; 1(8594):1116. PubMed ID: 2896952
    [No Abstract] [Full Text] [Related]

  • 17. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cantwell BM, Harris AL, Bozzino JM.
    Cancer Chemother Pharmacol; 1986 May 14; 18 Suppl 2():S29. PubMed ID: 3028660
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
    Scheulen ME, Niederle N, Bremer K, Schütte J, Seeber S.
    Cancer Treat Rev; 1983 Sep 14; 10 Suppl A():93-101. PubMed ID: 6414700
    [Abstract] [Full Text] [Related]

  • 19. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH, de Jong PE, Elema JD, Mulder NH.
    Cancer Chemother Pharmacol; 1989 Sep 14; 23(5):329-30. PubMed ID: 2495864
    [Abstract] [Full Text] [Related]

  • 20. Infusion of ifosfamide plus mesna.
    Rowland CG, Bradford E, Adams P, Haines-Nutt RP, Jakobson K.
    Lancet; 1984 Aug 25; 2(8400):468. PubMed ID: 6147537
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.